Direct determination of diastereomeric 13C-labeled ketoprofen glucuronides in human urine by nuclear magnetic resonance spectroscopy

Analytica Chimica Acta

Volumn 334, Issue 1-2, 1996, Pages 67-74

  Akira, Zazuki ^a   Shinohara, Yoshihiko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

13C labeling; Acylglucuronide; Cyclodextrin; Ketoprofen; Nuclear magnetic resonance spectrometry; Urine

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; DRUG METABOLITE; KETOPROFEN;

ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DIASTEREOISOMER; DRUG DETERMINATION; EXTRACTION; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RACEMIC MIXTURE; URINALYSIS; VOLUNTEER;

EID: 0030595801     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2670(96)00193-6     Document Type: Article

References (21)

1. [1] R.E. London, Prog. Nucl. Magn. Res. Spectrosc., 20 (1988) 337.
2. [2] T.J. Simpson, in E. Buncel and J.R. Jones (Eds.), Isotopes in the Physical and Biomedical Sciences, Vol. 2, Elsevier, Amsterdam, 1991, p. 431.
3. [3] M.C. Malet-Martino and R. Martino, Biochemie, 74 (1992) 785.
4. [4] S. Baba, K. Akira and C. Sakuma, Yakugaku Zasshi, 110 (1990) 586.
5. [5] K. Akira, N. Takagi, S. Takeo, H. Shindo and S. Baba, Anal. Biochem., 210 (1993) 86.
6. [6] K. Akira, R.D. Farrant, J.C. Lindon, S.T. Caddick, A.W. Nicholls and J.K. Nicholson, Anal. Biochem., 221 (1994) 297.
7. [7] S. Baba, K. Akira, H. Suzuki and M. Imachi, Biol. Pharm. Bull., 18 (1995) 643.
8. [8] K. Akira, H. Hasegawa and S. Baba, J. Labelled Compd. Radiopharm., 36 (1995) 845.
9. [9] A.M. Evans, Eur. J. Pharmacol., 42 (1992) 237.
10. [10] H. Spahn-Langguth and L.Z. Benet, Drug Metab. Rev., 24 (1992) 5.
11. [11] T. Ishizaki, T. Sasaki, T. Suganuma, Y. Horai, K. Chiba, M. Watanabe, W. Asuke and H. Hoshi, Eur. J. Clin. Pharmacol., 18 (1980) 407.
12. [12] R.T. Foster, F. Jamali, A.S. Russell and S.R. Alballa, J. Pharm. Sci., 77 (1988) 70.
13. [13] F. Jamali, A.S. Russell, R.T. Foster and C. Lemco, J. Pharm. Sci., 79 (1990) 460.
14. [14] R.T. Foster and F. Jamali, J. Chromatogr., 416 (1987) 388.
15. [15] Y. Mori, M. Shibata, K. Toyoshi, S. Baba, M. Horie, Y. Oshika and K. Ohira, Radioisotopes, 30 (1981) 584.
16. [16] G. Bradow, L.-S. Kan and C. Fenselau, Chem. Res. Toxicol., 2 (1989) 316.
17. [17] F.Y.K. Ghauri, C.A. Blackledge, I.D. Wilson and J.K. Nicholson, J. Pharm. Biomed. Anal., 8 (1990) 939.
18. [18] A. Taylor, D.A.R. Williams and I.D. Wilson, J. Pharm. Biomed. Anal., 9 (1991) 493.
19. [19] A. Taylor, C.A. Blackledge, J.K. Nicholson, D.A.R. Williams and I.D. Wilson, Anal. Proc., 29 (1992) 229.
20. [20] P.J. Hayball, R.L. Nation and F. Bochner, Biochem. Pharmacol., 44 (1992) 291.
21. [21] N. Dubois, F. Lapicque, M.-H. Maurice, M. Pritchard, S. Fournel-Gigleux, J. Magdalou, M. Abiteboul, G. Siest and P. Netter, Drug Metab. Dispos., 21 (1993) 617.